Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2007
10/16/2007US7282494 Heteroaryl diazacycloalkanes, their preparation and use
10/16/2007US7282469 Herbicides
10/16/2007CA2419194C Cyclopentyl modulators of chemokine receptor activity
10/16/2007CA2352204C Enantioselective alkylation of tricyclic compounds
10/16/2007CA2327253C Sulfonamide-containing indole compounds
10/16/2007CA2261829C Intermediates for the preparation of 2-imidazoline-5-ones
10/11/2007WO2007114827A1 Substituted heterocyclic compounds and methods of use
10/11/2007WO2007114771A1 2-AMINOPYRIMIDIN-4-ONES AND THEIR USE FOR TREATING OR PREVENTING Aβ-RELATED PATHOLOGIES
10/11/2007WO2007114763A1 Sulphonamide derivates as modulators of the glucocorticoid receptor
10/11/2007WO2007114338A1 Acid secretion inhibitor
10/11/2007WO2007114323A1 Aminopyrrolidine compound
10/11/2007WO2007114213A1 Substituted bicyclic cyclic derivative and use thereof
10/11/2007WO2007113327A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
10/11/2007WO2007113276A1 Novel bi-aryl amines
10/11/2007WO2007113261A1 Process for preparing heterocyclic derivatives
10/11/2007WO2007113260A1 Azabicyclo [3. 1. o] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007113258A1 Azabicyclo [3. 1. o] hexane derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007113256A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
10/11/2007WO2007113254A1 Hiv inhibiting 5-amido substituted pyrimidines
10/11/2007WO2007113232A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007WO2007112913A2 Benzimidazole derivatives
10/11/2007WO2007112842A1 Active ingredient combinations with insecticidal properties
10/11/2007WO2007095561A3 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
10/11/2007WO2006123165A3 Pyrimidine derivatives as hsp90 inhibitors
10/11/2007WO2006094763A8 3,4,5-substituted piperidine compounds
10/11/2007WO2006086381A3 Hepatitis c virus inhibitors
10/11/2007WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007US20070238880 Diastereoselective Synthesis Process for the Preparation of Imidazole Compounds
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238756 Combinations of dipeptidyl peptidase iv inhibitors and other antidiabetic agents for the treatment of diabetes mellitus
10/11/2007US20070238754 1-Cyclohexylmethyl-5-(2,5-dimethoxy-phenyl)-2-methyl-1H-pyrrole-3-carboxylic acid cyclohexylamide and 2-(5-Chloro-2-methoxy-phenyl)-1-(2-cyclohexyl-ethyl)-5-methyl-1H-imidazole-4-carboxylic acid cyclohexylamide; treating obesity, eating disorders; antidiabetic agents; antiinflammatory agents; drug abuse
10/11/2007US20070238753 Pharmaceutical Compositions as Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)
10/11/2007US20070238740 Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use
10/11/2007US20070238736 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-[4-(Benzo [1,3]dioxole-5-carbonyl)-piperazin-1-yl]-1-(4-fluoro-benzyl)-2-oxo-1,2-dihydro-quinoline-3-carbonitrile; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/11/2007US20070238727 5-Substituted 1-Phenyl-1,5-Dihydro-Pyrido[3,2-B]Indol-2-Ones and Analogs as Anti-Virals
10/11/2007US20070238722 N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones
10/11/2007DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system
10/11/2007CA2648443A1 Substituted heterocyclic compounds and methods of use
10/11/2007CA2648089A1 Process for preparing heterocyclic derivatives
10/11/2007CA2648087A1 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
10/11/2007CA2647862A1 Acid secretion inhibitor
10/11/2007CA2647811A1 Substituted bicyclic derivative and use thereof
10/11/2007CA2646755A1 Bicyclic benzimidazole compounds and their use as metabotropic glutamate receptor potentiators
10/11/2007CA2646088A1 Novel bi-aryl amines
10/11/2007CA2645959A1 Hiv inhibiting 5-(hydroxymethylene and aminomethylene) substituted pyrimidines
10/11/2007CA2645958A1 Hiv inhibiting 5-amido substituted pyrimidines
10/11/2007CA2644380A1 Benzimidazole derivatives
10/10/2007EP1842846A1 Phenylpiperidine derivatives as melanocortin-4 receptor modulators
10/10/2007EP1842845A1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
10/10/2007EP1841760A2 Pyrimidine derivatives as kinase modulators and method of use
10/10/2007EP1841758A1 Substituted triazole derivatives as oxytocin antagonists
10/10/2007EP1841757A2 Heteroaromatic quinoline compounds and their use as pde10 inhibitors
10/10/2007EP1841756A1 3-heterocyclyl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841755A1 Substituted indole ligands for the orl-1 receptor
10/10/2007EP1841744A1 1-phenyl-3-piperazine-pyrazoles and pesticidal compositions of matter thereof
10/10/2007EP1841743A1 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
10/10/2007EP1841741A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
10/10/2007EP1841740A1 3,4,(5)-substituted tetrahvdropyridines
10/10/2007EP1841737A1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
10/10/2007EP1841736A1 Indoles useful in the treatment of inflammation
10/10/2007EP1841735A1 Indoles useful in the treatment of inflammation
10/10/2007EP1610792B1 Calcium channel blockers comprising two benzhydril moieties
10/10/2007EP1581515B1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/10/2007EP1501824B1 A method for the purification of lansoprazole
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1421076B1 Hydrates of optionally substituted 2-(2-pyridinyl)methylthio-1h-benzimidazoles and method for the production thereof
10/10/2007EP1379525B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007EP1142879B1 Imidazole compounds and medicinal use thereof
10/10/2007CN101052638A 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
10/10/2007CN101052635A Chemical compounds
10/10/2007CN101052634A Anthranilamide pyridinureas as vegf receptor kinase inhibitors
10/10/2007CN101052633A Methods of preparing indazole compounds
10/10/2007CN101052627A Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
10/10/2007CN101052625A Adamantyl derivates as p2x7 receptor antagonists
10/10/2007CN101052621A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
10/10/2007CN101052620A Benzamide compound
10/10/2007CN101052394A Treatment of acute myeloid leukemia with indolinone compounds
10/10/2007CN101050212A Method for extracting high pure natural nicotine and solanesol at same time from waste and low-grade tobacco
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279578 Use as orexin receptor antagonists, depression; anxiety; addictions; obsessive compulsive disorder; affective neurosis; depressive neurosis; anxiety neurosis; dysthymic disorder; behaviour disorder; mood disorder; sexual dysfunction; psychosexual dysfunction; schizophrenia; manic depression; delerium
10/09/2007US7279574 Heat conductivity, it is also useful as an insulating material requiring high heat releasability such as a printed circuit substrate
10/09/2007US7279498 Substituted aryl amides as IP antagonists
10/09/2007US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell
10/09/2007US7279491 Phenylpiperidines and phenylpyrrolidines
10/09/2007US7279490 Ophthalmic compositions for treating ocular hypertension
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279488 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions
10/09/2007US7279486 Therapy and prophylaxis of pain, central nervous system diseases; 2-Benzyl-3-(2,3-dihydro-1'H-spiro[indene-1,4'-piperidin]-1'-yl)propanoic acid trifluoroacetate
10/09/2007US7279481 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone; therapy of depression or anxiety
10/09/2007US7279480 Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279475 Cytokine inhibitors, useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease; for example, 1-(2-methoxy-5-trifluoromethyl-phenyl)-3-{4-[6-methyl-2-(2-morpholin-4-yl-ethyl)-pyrimidin-4-yloxy]-naphthalen-1-yl}-urea
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279469 Diaminotriazoles useful as inhibitors of protein kinases
10/09/2007US7279444 for controlling undesirable plants
10/09/2007US7279314 Chemical substance having morphogenetic and growth-accelerating activities
1 ... 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 ... 1080